title: Cyclooxygenase-1 inhibition prolongs postnatal ovarian follicle lifespan in mice.
abstract: Menopause is the permanent cessation of menstruation that results from depletion of ovarian germ cells and follicles. Although most animals experience reproductive senescence, the mechanisms differ from that in women, who may live more than one-third of their lives after menopause and consequently face the risk of a number of menopause-associated health problems. Understanding factors that influence ovarian aging may provide strategies to delay or alleviate physiological alterations that take place in postmenopausal women. The germ cell-deficient Wv mice recapitulate follicle loss, prolong postreproductive lifespan, and model many physiological changes that take place in postmenopausal women. Here, using genetic and pharmacological approaches, we found that inhibition of cyclooxygenase-1 but not cyclooxygenase-2 in Wv mice delays germ cell depletion and preserves ovarian follicles. Cyclooxygenase-1 inhibition slows down follicle maturation at the conversion of primary to secondary follicles and prolongs postnatal ovarian follicle lifespan. The current study suggests that inhibition of cyclooxygenase-1 may be able to delay ovarian aging and modulate menopausal timing.
authors: Department of Cell Biology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
authors: Elizabeth R
authors: ER
authors: Smith
authors: Wan-Lin
authors: WL
authors: Yang
authors: Toni
authors: T
authors: Yeasky
authors: Jennifer
authors: J
authors: Smedberg
authors: Kathy Q
authors: KQ
authors: Cai
authors: Xiang-Xi
authors: XX
authors: Xu
mesh_terms: D000375:Aging; D000818:Animals; D000068579:Celecoxib; D003433:Crosses, Genetic; D051545:Cyclooxygenase 1 / Q000235:genetics / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D005260:Female; D007213:Indomethacin / Q000627:therapeutic use; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D008593:Menopause / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D006080:Ovarian Follicle / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism / Q000473:pathology; D016649:Primary Ovarian Insufficiency / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D011720:Pyrazoles / Q000627:therapeutic use; D011897:Random Allocation; D046468:Sexual Development / Q000187:drug effects; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D008565:Membrane Proteins; D011720:Pyrazoles; C115461:SC 560; D013449:Sulfonamides; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496512:Ptgs1 protein, mouse; D000068579:Celecoxib; D007213:Indomethacin
keywords: cyclooxygenase; follicular development; menopause; ovarian follicles
references: Adv Immunol. 1996;62:167-215
references: 8781269
references: Am J Pathol. 2007 Apr;170(4):1325-36
references: 17392171
references: Cell. 1997 Oct 17;91(2):197-208
references: 9346237
references: Maturitas. 2010 Sep;67(1):34-8
references: 20570066
references: Mol Cell Endocrinol. 2000 May 25;163(1-2):43-8
references: 10963872
references: Prostaglandins Other Lipid Mediat. 2006 Oct;81(1-2):45-54
references: 16997131
references: Cell. 1995 Nov 3;83(3):483-92
references: 8521478
references: Hum Reprod. 1996 Jul;11(7):1484-6
references: 8671489
references: EMBO J. 1990 Jun;9(6):1805-13
references: 1693331
references: J Reprod Fertil. 1968 Dec;17(3):555-7
references: 5715685
references: EMBO J. 2000 Mar 15;19(6):1312-26
references: 10716931
references: Cancer Res. 2006 Mar 1;66(5):2527-31
references: 16510568
references: Gynecol Oncol. 2006 Nov;103(2):719-28
references: 16698071
references: Endocrinology. 1999 Jun;140(6):2685-95
references: 10342859
references: Obstet Gynecol Clin North Am. 2011 Sep;38(3):425-40
references: 21961711
references: J Natl Cancer Inst. 1972 May;48(5):1283-95
references: 4337905
references: Nat Genet. 2009 Jun;41(6):724-8
references: 19448621
references: Gastroenterology. 2004 Jul;127(1):94-104
references: 15236176
references: Oncogene. 2010 Feb 11;29(6):781-8
references: 19946329
references: Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):77-84
references: 20381633
references: J Soc Gynecol Investig. 2002 May-Jun;9(3):168-73
references: 12009392
references: Biol Reprod. 2009 Jul;81(1):16-25
references: 19264701
references: Reproduction. 2007 Jan;133(1):117-25
references: 17244738
references: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2890-4
references: 11867735
references: Biol Reprod. 2003 Mar;68(3):804-11
references: 12604629
references: Biol Reprod. 1995 Oct;53(4):775-9
references: 8547469
references: Menopause. 2012 May;19(5):588-96
references: 22228319
references: Cancer Res. 1973 Apr;33(4):721-3
references: 4696472
references: Endocrinology. 1999 Sep;140(9):4262-71
references: 10465300
references: Nat Med. 2012 Jan 06;18(1):32-3
references: 22227665
references: J Exp Zool. 1957 Mar;134(2):207-37
references: 13428952
references: Nat Genet. 2009 Jun;41(6):637-8
references: 19471299
references: Biochem Pharmacol. 1999 Oct 15;58(8):1237-46
references: 10487525
references: Cancer Res. 2001 Aug 15;61(16):6131-6
references: 11507063
references: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5229-34
references: 17360389
references: Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):903-6
references: 11489759
references: Nat New Biol. 1971 Jun 23;231(25):232-5
references: 5284360
references: Development. 2008 Mar;135(5):839-47
references: 18216169
references: Cancer Res. 2007 Jun 1;67(11):5285-92
references: 17545608
references: Cancer Res. 2000 Sep 1;60(17):4705-8
references: 10987272
references: Genes Dev. 1990 Mar;4(3):390-400
references: 1692559